« Previous
Next »
Gastroenterology
Volume 117, Issue 3
, Pages 626-631
, September 1999
Prognostic value of early measurements of portal pressure in acute variceal bleeding
References
- . The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800–809
- . Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology. 1989;9:801–807
- . Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5:419–424
- . Hemodynamic events in a prospective randomized trial of propranolol vs. placebo in the prevention of the first variceal hemorrhage. Gastroenterology. 1990;99:1401–1407
- . Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Hepatology. 1993;18:1082–1089
- . Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology. 1984;4:1200–1205
- . Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis. 1986;6:318–331
- . Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989;96:873–880
- . Assessment of short-therm prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology. 1986;6:116–117
- . Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology. 1991;100:1403–1410
- . Definitions, methodology and therapeutic strategies in portal hypertension. A consensus development workshop J Hepatol. 1992;15:256–261
- . Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis. 1986;6:309–317
-
.
Clinical manifestations and management of bleeding episodes in cirrhotics.
In: 2nd ed.
Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodés J editor.
Oxford textbook of clinical hepatology. Oxford, England: Oxford University Press; 1999;p. 671–693
-
.
Sore points.
In: Proceedings of the second Baveno international consensus workshop on definitions, methodology and therapeutic strategies.
de Franchis editors.
Portal hypertension II. Oxford, England:: Blackwell Science; 1996;p. 10–17
- . The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–353
- . The hepatic venous pressure gradient: has the time arrived for its application in clinical practice?. Hepatology. 1996;24:739–741
- . Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology. 1996;111:701–709
- . Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut. 1999;44:264–269
- . Prognostic value of portal haemodynamics. Lancet. 1995;346:1046–1047
-
.
Tratamiento de la hemorragia por varices esofágicas en relación al gradiente de presión portal. Resultados preliminares (abstr).
Gastroenterol Hepatol. 1999;22(suppl 1):39
- . Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis?. Hepatology. 1997;25:245–248
- . Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 1995;346:1056–1059
- . Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 1992;102:973–979
- . Hemodynamic evaluation of patients with intrahepatic portal hypertension: relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975;69:1297–1300
- . Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980;79:1139–1144
- . Clinical events following transjugular intrahepatic porta-systemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998;114:1296–1303
- . Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention. N Engl J Med. 1996;334:1624–1629
☆ Address requests for reprints to: Jaime Bosch, M.D., Liver Unit, Hospital Clinic, Villarroel 170, 08036 Barcelona, Spain. e-mail: jbosch@medicina.ub.es; fax: (34) 934-515-522.
☆☆ Supported in part by grant FIS 97/1309 from the Fondo de Investigación Sanitaria. Dr. Moitinho was supported by grants FIS 97/5617 and FIS 98/9470 from the Hospital Clinic and from Fondo de Investigación Sanitaria.
PII: S0016-5085(99)70455-5
© 1999 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 117, Issue 3
, Pages 626-631
, September 1999

